Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers
February 2017
in “Aaps Pharmscitech”
TLDR Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.
This document describes the development of a nanostructured lipid carrier (NLC) for the topical delivery of minoxidil (MXD) to treat hair loss. The NLCs were composed of stearic acid, oleic acid, and surfactants, and showed better stability and retention in the skin than solid lipid nanoparticles (SLNs). The study suggests that NLCs are a promising drug delivery system for MXD and could improve patient acceptance and tolerability for the topical delivery of MXD.
View this study on link.springer.com →
Cited in this study
research Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route
research Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss
Six new hair loss factors in men not linked to female hair loss.
research Molecular mechanisms of androgenetic alopecia
AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.
research Androgenetic alopecia in men and women
Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.
research Androgenetic Alopecia: In Vivo Models
Stump-tailed macaque best for researching hair loss causes and treatments.
Related
research Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers
Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.
research Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability
Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.